Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe ...
May 17, 2022
0
34
Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.
Apr 28, 2022
0
55
New research results demonstrate how inflammation from a COVID-19 infection during pregnancy could potentially impact long-term infant health, including infant growth and brain development. Published in the Journal of Perinatology, ...
Apr 25, 2022
0
61
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23-26 April) has identified a panel of cytokines that can help predict which COVID-19 ...
Apr 23, 2022
0
24
A UCLA-led team of researchers studying the effect of the monoclonal antibody Leronlimab on long COVID-19 may have found a surprising clue to the baffling syndrome, one that contradicts their initial hypothesis. An abnormally ...
Apr 22, 2022
1
675
Axicabtagene ciloleucel (axi-cel; Yescarta) was approved for treatment of large B-cell lymphoma (LBCL) that is refractory to first-line chemoimmunotherapy or relapses within a year of first-line chemotherapy, the U.S. Food ...
Apr 15, 2022
0
3
Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.
Apr 6, 2022
0
21
The vast majority of people infected with the Omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep ...
Mar 30, 2022
0
212
Using their novel organ-on-a-chip platform, a research team from the University of Toronto's Faculty of Applied Science & Engineering has identified a molecule with the potential to combat one of the most severe complications ...
Mar 28, 2022
0
26
Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and ...
Mar 23, 2022
0
70
